重组胶原蛋白的产业发展历程和生物医学应用前景展望
日期:2023-06-01 11:07
状态:待解决
提问:kjcxac
utics in development for epidermolysis bullosa: update 2020. Mol Diagn Ther, 2020, 24(3): 299-309. DOI:10.1007/s40291-020-00466-7
[96]Remington J, Wang XY, Hou YP, et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther, 2009, 17(1): 26-33. DOI:10.1038/mt.2008.234
[97]A Phase 1/2 Trial of PTR-01 in Adult Patients with Recessive Dystrophic Epidermolysis Bullosa (EB/RD). Available online: https://Clini
最佳答案:
暂无最佳答案
[全部回答(0)] [我来回答]
96/100 下一页 上一页 首页 尾页
返回 |  刷新 |  WAP首页 |  网页版  | 登录
04/20 06:00